Overexpression of glucocorticoid receptor in human pancreatic cancer and in xenografts. An immunohistochemical study

Sándor Békási, A. Zalatnai

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Glucocorticoid receptor overexpression has been reported in a variety of human solid tumors, but much less in known about its presence in pancreatic cancer. Only one report is available in the literature, back to 1994, since that no peculiar attention has been paid to this issue. Immunohistochemical analysis of paraffin-embedded tissue sections was performed in human normal pancreata and well differentiated pancreatic adenocarcinomas (monoclonal primary antibody, ABCAM, Cambridge, UK). As positive control invasive ductal adenocarcinoma of the breast was used. In the normal non-tumorous pancreas a strong positivity was detected in all acinar cells, typically in the cytoplasm. Nuclear staining was not visible. The distribution of the positive reaction was homogenous. The ductal pancreatic carcinoma cells also displayed a strong positivity. The location of the immune reaction was mainly cytoplasmic but in some tumors a strong nuclear reaction was also noticed. In some slides acini remained also positive in the close vicinity of the tumor. Although the positivity of the ductal tumor cells was a constant finding in our samples, surprisingly, the liver metastasis was completely negative. Strong glucocorticoid receptor expression was also found in xenografted human pancreatic cancer showing a diffuse, mainly cytoplasmic positivity. Our studies have shown that the human pancreatic carcinomas do overexpress a strong glucocorticoid receptor positivity, but its significance is not clear. However, this finding might have a clinical relevance.

Original languageEnglish
Pages (from-to)561-566
Number of pages6
JournalPathology and Oncology Research
Volume15
Issue number4
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Glucocorticoid Receptors
Pancreatic Neoplasms
Heterografts
Pancreas
Neoplasms
Adenocarcinoma
Pancreatic Ductal Carcinoma
Acinar Cells
Paraffin
Cytoplasm
Breast
Monoclonal Antibodies
Staining and Labeling
Neoplasm Metastasis
Liver

Keywords

  • Glucocorticoid receptor
  • Immunohistochemistry
  • Pancreatic cancer
  • Xenograft

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pathology and Forensic Medicine

Cite this

Overexpression of glucocorticoid receptor in human pancreatic cancer and in xenografts. An immunohistochemical study. / Békási, Sándor; Zalatnai, A.

In: Pathology and Oncology Research, Vol. 15, No. 4, 12.2009, p. 561-566.

Research output: Contribution to journalArticle

@article{c4135994198c4b4e93aac45aa1a0cfd5,
title = "Overexpression of glucocorticoid receptor in human pancreatic cancer and in xenografts. An immunohistochemical study",
abstract = "Glucocorticoid receptor overexpression has been reported in a variety of human solid tumors, but much less in known about its presence in pancreatic cancer. Only one report is available in the literature, back to 1994, since that no peculiar attention has been paid to this issue. Immunohistochemical analysis of paraffin-embedded tissue sections was performed in human normal pancreata and well differentiated pancreatic adenocarcinomas (monoclonal primary antibody, ABCAM, Cambridge, UK). As positive control invasive ductal adenocarcinoma of the breast was used. In the normal non-tumorous pancreas a strong positivity was detected in all acinar cells, typically in the cytoplasm. Nuclear staining was not visible. The distribution of the positive reaction was homogenous. The ductal pancreatic carcinoma cells also displayed a strong positivity. The location of the immune reaction was mainly cytoplasmic but in some tumors a strong nuclear reaction was also noticed. In some slides acini remained also positive in the close vicinity of the tumor. Although the positivity of the ductal tumor cells was a constant finding in our samples, surprisingly, the liver metastasis was completely negative. Strong glucocorticoid receptor expression was also found in xenografted human pancreatic cancer showing a diffuse, mainly cytoplasmic positivity. Our studies have shown that the human pancreatic carcinomas do overexpress a strong glucocorticoid receptor positivity, but its significance is not clear. However, this finding might have a clinical relevance.",
keywords = "Glucocorticoid receptor, Immunohistochemistry, Pancreatic cancer, Xenograft",
author = "S{\'a}ndor B{\'e}k{\'a}si and A. Zalatnai",
year = "2009",
month = "12",
doi = "10.1007/s12253-009-9154-0",
language = "English",
volume = "15",
pages = "561--566",
journal = "Pathology and Oncology Research",
issn = "1219-4956",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Overexpression of glucocorticoid receptor in human pancreatic cancer and in xenografts. An immunohistochemical study

AU - Békási, Sándor

AU - Zalatnai, A.

PY - 2009/12

Y1 - 2009/12

N2 - Glucocorticoid receptor overexpression has been reported in a variety of human solid tumors, but much less in known about its presence in pancreatic cancer. Only one report is available in the literature, back to 1994, since that no peculiar attention has been paid to this issue. Immunohistochemical analysis of paraffin-embedded tissue sections was performed in human normal pancreata and well differentiated pancreatic adenocarcinomas (monoclonal primary antibody, ABCAM, Cambridge, UK). As positive control invasive ductal adenocarcinoma of the breast was used. In the normal non-tumorous pancreas a strong positivity was detected in all acinar cells, typically in the cytoplasm. Nuclear staining was not visible. The distribution of the positive reaction was homogenous. The ductal pancreatic carcinoma cells also displayed a strong positivity. The location of the immune reaction was mainly cytoplasmic but in some tumors a strong nuclear reaction was also noticed. In some slides acini remained also positive in the close vicinity of the tumor. Although the positivity of the ductal tumor cells was a constant finding in our samples, surprisingly, the liver metastasis was completely negative. Strong glucocorticoid receptor expression was also found in xenografted human pancreatic cancer showing a diffuse, mainly cytoplasmic positivity. Our studies have shown that the human pancreatic carcinomas do overexpress a strong glucocorticoid receptor positivity, but its significance is not clear. However, this finding might have a clinical relevance.

AB - Glucocorticoid receptor overexpression has been reported in a variety of human solid tumors, but much less in known about its presence in pancreatic cancer. Only one report is available in the literature, back to 1994, since that no peculiar attention has been paid to this issue. Immunohistochemical analysis of paraffin-embedded tissue sections was performed in human normal pancreata and well differentiated pancreatic adenocarcinomas (monoclonal primary antibody, ABCAM, Cambridge, UK). As positive control invasive ductal adenocarcinoma of the breast was used. In the normal non-tumorous pancreas a strong positivity was detected in all acinar cells, typically in the cytoplasm. Nuclear staining was not visible. The distribution of the positive reaction was homogenous. The ductal pancreatic carcinoma cells also displayed a strong positivity. The location of the immune reaction was mainly cytoplasmic but in some tumors a strong nuclear reaction was also noticed. In some slides acini remained also positive in the close vicinity of the tumor. Although the positivity of the ductal tumor cells was a constant finding in our samples, surprisingly, the liver metastasis was completely negative. Strong glucocorticoid receptor expression was also found in xenografted human pancreatic cancer showing a diffuse, mainly cytoplasmic positivity. Our studies have shown that the human pancreatic carcinomas do overexpress a strong glucocorticoid receptor positivity, but its significance is not clear. However, this finding might have a clinical relevance.

KW - Glucocorticoid receptor

KW - Immunohistochemistry

KW - Pancreatic cancer

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=75049083170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75049083170&partnerID=8YFLogxK

U2 - 10.1007/s12253-009-9154-0

DO - 10.1007/s12253-009-9154-0

M3 - Article

VL - 15

SP - 561

EP - 566

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

SN - 1219-4956

IS - 4

ER -